These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18363709)

  • 1. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country.
    Picot MC; Baldy-Moulinier M; Daurès JP; Dujols P; Crespel A
    Epilepsia; 2008 Jul; 49(7):1230-8. PubMed ID: 18363709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, demographic and spatial distribution of treated epilepsy in France in 2020: a study based on the French national health data system.
    Coste J; Mandereau-Bruno L; Carcaillon-Bentata L; Mikaeloff Y; Bouilleret V
    J Neurol; 2024 Jan; 271(1):519-525. PubMed ID: 37787813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.
    Kwan P; Arzimanoglou A; Berg AT; Brodie MJ; Allen Hauser W; Mathern G; Moshé SL; Perucca E; Wiebe S; French J
    Epilepsia; 2010 Jun; 51(6):1069-77. PubMed ID: 19889013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant epilepsy.
    Kwan P; Schachter SC; Brodie MJ
    N Engl J Med; 2011 Sep; 365(10):919-26. PubMed ID: 21899452
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore.
    Kong ST; Ho CS; Ho PC; Lim SH
    Epilepsy Res; 2014 Sep; 108(7):1253-62. PubMed ID: 24910376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILAE official report: a practical clinical definition of epilepsy.
    Fisher RS; Acevedo C; Arzimanoglou A; Bogacz A; Cross JH; Elger CE; Engel J; Forsgren L; French JA; Glynn M; Hesdorffer DC; Lee BI; Mathern GW; Moshé SL; Perucca E; Scheffer IE; Tomson T; Watanabe M; Wiebe S
    Epilepsia; 2014 Apr; 55(4):475-82. PubMed ID: 24730690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of epilepsy in the U.S. population: A different approach.
    Helmers SL; Thurman DJ; Durgin TL; Pai AK; Faught E
    Epilepsia; 2015 Jun; 56(6):942-8. PubMed ID: 25921003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.
    Fiest KM; Sauro KM; Wiebe S; Patten SB; Kwon CS; Dykeman J; Pringsheim T; Lorenzetti DL; Jetté N
    Neurology; 2017 Jan; 88(3):296-303. PubMed ID: 27986877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct cost of epilepsy in the United States: A systematic review of estimates.
    Begley CE; Durgin TL
    Epilepsia; 2015 Sep; 56(9):1376-87. PubMed ID: 26216617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.
    Kessler SK; McCarthy A; Cnaan A; Dlugos DJ
    Epilepsy Res; 2015 May; 112():18-26. PubMed ID: 25847334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.
    Hamer HM; Dodel R; Strzelczyk A; Balzer-Geldsetzer M; Reese JP; Schöffski O; Graf W; Schwab S; Knake S; Oertel WH; Rosenow F; Kostev K
    J Neurol; 2012 Nov; 259(11):2376-84. PubMed ID: 22544296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the underlying cause of epilepsy a major prognostic factor for recurrence?
    Semah F; Picot MC; Adam C; Broglin D; Arzimanoglou A; Bazin B; Cavalcanti D; Baulac M
    Neurology; 1998 Nov; 51(5):1256-62. PubMed ID: 9818842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and quality of life following surgical treatment for refractory epilepsy: a systematic review and meta-analysis.
    Liu SY; Yang XL; Chen B; Hou Z; An N; Yang MH; Yang H
    Medicine (Baltimore); 2015 Feb; 94(6):e500. PubMed ID: 25674741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resective epilepsy surgery for drug-resistant focal epilepsy: a review.
    Jobst BC; Cascino GD
    JAMA; 2015 Jan; 313(3):285-93. PubMed ID: 25602999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacoresistant epilepsy - epidemiology and current studies].
    Pierzchala K
    Neurol Neurochir Pol; 2010; 44(3):285-90. PubMed ID: 20648993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The descriptive epidemiology of epilepsy-a review.
    Banerjee PN; Filippi D; Allen Hauser W
    Epilepsy Res; 2009 Jul; 85(1):31-45. PubMed ID: 19369037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.
    Hauser WA; Annegers JF; Kurland LT
    Epilepsia; 1991; 32(4):429-45. PubMed ID: 1868801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.
    Kalilani L; Sun X; Pelgrims B; Noack-Rink M; Villanueva V
    Epilepsia; 2018 Dec; 59(12):2179-2193. PubMed ID: 30426482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY; Wu N; Boulanger L; Sacco P
    J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and incidence of epilepsy in Italy based on a nationwide database.
    Giussani G; Cricelli C; Mazzoleni F; Cricelli I; Pasqua A; Pecchioli S; Lapi F; Beghi E
    Neuroepidemiology; 2014; 43(3-4):228-32. PubMed ID: 25412652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.